SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Amazon Explores AI Content Marketplace With Media Publishers 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
IRVINE, Calif., Feb. 20, 2018 -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief Financial Officer, and Talya Nevo-Hacohen, the company’s Chief Investment Officer, will participate in Citi’s Global Property CEO Conference being held March 5 – March 7, 2018 in Hollywood, FL.
About Sabra
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
CONTACT:
Investor & Media Inquiries: 1-888-393-8248 or [email protected]
